Apamistamab Biosimilar, PTPRC/CD45 Antibody | C133P

Apamistamab Biosimilar, PTPRCCD45 Antibody C133P Syd Labs | Ushelf

Apamistamab Biosimilar, PTPRC/CD45 Antibody | C133P

$200.00 – $2,000.00

In stock
Catalog No.: C133P | In Vivo Grade

$200.00 – $2,000.00

The research grade Apamistamab biosimilar protein is for research use only (RUO). Recombinant Human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.

Clear
View cart
Catalog No. C133P
Product Name Apamistamab Biosimilar, PTPRC/CD45 Monoclonal Antibody
Supplier Name Syd Labs, Inc.
Brand Name Syd Labs
Isotype Human IgG1 kappa.
Source/Host The anti-PTPRC/CD45 monoclonal antibody apamistamab biosimilar was produced in mammalian cells.
Specificity/Sensitivity The in vivo grade apamistamab biosimilar specifically binds to the PTPRC/CD45 protein.
Applications ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by apamistamab.
Form Of Antibody 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.
Endotoxin < 1 EU per 1 mg of the protein by the LAL method.
Purity >95% by SDS-PAGE under reducing conditions and HPLC.
Shipping The research grade apamistamab biosimilar is shipped with ice packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
Note The research grade Apamistamab biosimilar protein is for research use only (RUO). Recombinant Human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Order Offline Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card.

Description

C133P: Apamistamab Biosimilar, PTPRC/CD45 Monoclonal Antibody

Recombinant Humanized IgG1 Monoclonal Antibody.